The drugmaker said it is in active dialogue with the regulator and its contract development and manufacturing organization (CDMO) customers about the matter.
The acquisition will add nasal spray and sterile dosage expertise to German company LTS Lohmann’s CDMO network in effort to strengthen its U.S. and global operations.
Join us for a high-impact roundtable where industry leaders explore how digital transformation is revolutionizing the manufacturing of new modalities—unlocking the full potential of personalized, scalable, and rapidly delivered therapies.
